Who Supplies Losartan? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Losartan exports, with 506+ registered manufacturers shipping to buyers across 141+ countries — yet a handful of companies dominate the shipments. ZYDUS LIFESCIENCES LIMITED holds the largest share at 20.7% (export value: $62.3M). Close behind, CIPLA LIMITED (4.7%, $14.0M). LUPIN LIMITED (3.2%, $9.7M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Losartan? Top Manufacturers & Their Buyers
Flow of Losartan from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Losartan Supplier Network — Key Market Intelligence
The Losartan export market from India is led by ZYDUS LIFESCIENCES LIMITED, which alone commands a 20.7% share, shipping $62.3M worth of product across 562 shipments. The second-largest exporter, CIPLA LIMITED, contributes $14.0M (4.7%) to the overall market. Combined, the top two suppliers alone account for 25.3% of all Losartan exports, indicating a relatively concentrated supply base.
Across all 506 tracked manufacturers, the total Losartan export value stands at $301.0M from 10.9K shipments. The market average shipment value is $27.6K. The single largest buyer relationship in terms of trade value is EVERSANA LIFE SCIENCE SERVICES, receiving $56.1M worth of product.
The combined buyer network spans 22 named purchasing companies, including EVERSANA LIFE SCIENCE SERVICES, PRIORITY HEALTHCARE , SUNSHINE HEALTHCARE LANKA LIMITED, ABACUS PHARMA (AFRIC, BREATHEFREE LANKA PVT LTD and 17 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1ZYDUS LIFESCIENCES LIMITED
ZYDUS LIFESCIENCES LIMITED is the first-largest Losartan exporter from India, with a market share of 20.7% and a total export value of $62.3M across 562 shipments. Their average shipment value of $110.8K is above the market average of $27.6K, suggesting premium or bulk contract pricing.
ZYDUS LIFESCIENCES LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES is the dominant customer, accounting for 90.2% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCE SERVICES — $56.1M across 507 shipments (90.2% of this supplier's total exports)
• PRIORITY HEALTHCARE — $1.8M across 16 shipments (2.9% of this supplier's total exports)
• SUNSHINE HEALTHCARE LANKA LIMITED — $1.7M across 15 shipments (2.7% of this supplier's total exports)
• PRIORITY HEALTHCARE — $1.6M across 15 shipments (2.6% of this supplier's total exports)
• ABACUS PHARMA (AFRIC — $1.0M across 9 shipments (1.6% of this supplier's total exports)
Key Insight: ZYDUS LIFESCIENCES LIMITED's per-shipment value of $110.8K is 301% above the market average of $27.6K, consistent with large-order contracts or value-added formulations.
2CIPLA LIMITED
CIPLA LIMITED is the second-largest Losartan exporter from India, with a market share of 4.7% and a total export value of $14.0M across 184 shipments. Their average shipment value of $76.1K is above the market average of $27.6K, suggesting premium or bulk contract pricing.
CIPLA LIMITED serves 5 named buyers in our database. BREATHEFREE LANKA PVT LTD is the dominant customer, accounting for 73.3% of this supplier's tracked business. Top customers include:
• BREATHEFREE LANKA PVT LTD — $10.3M across 135 shipments (73.3% of this supplier's total exports)
• BREATHEFREE LANKA PR — $2.0M across 26 shipments (14.4% of this supplier's total exports)
• OPHAM — $1.5M across 20 shipments (10.9% of this supplier's total exports)
• SOMAPHAR SA — $165.4K across 2 shipments (1.2% of this supplier's total exports)
• NA — $34.7K across 0 shipments (0.2% of this supplier's total exports)
Key Insight: CIPLA LIMITED's per-shipment value of $76.1K is 176% above the market average of $27.6K, consistent with large-order contracts or value-added formulations.
3LUPIN LIMITED
LUPIN LIMITED is the third-largest Losartan exporter from India, with a market share of 3.2% and a total export value of $9.7M across 360 shipments. Their average shipment value of $27.0K is below the market average of $27.6K, reflecting a high-volume, competitive pricing strategy.
LUPIN LIMITED serves 5 named buyers in our database. UPS SUPPLY CHAIN SOL is the dominant customer, accounting for 70.5% of this supplier's tracked business. Top customers include:
• UPS SUPPLY CHAIN SOL — $6.8M across 254 shipments (70.5% of this supplier's total exports)
• UPD LEA GLEN, PHARMA — $1.3M across 48 shipments (13.2% of this supplier's total exports)
• UPD LEA GLEN PHARMA — $882.1K across 33 shipments (9.1% of this supplier's total exports)
• UPD LEA GLEN PHARMA — $479.5K across 18 shipments (4.9% of this supplier's total exports)
• 1920 OUTER LOOP ROAD — $224.5K across 8 shipments (2.3% of this supplier's total exports)
Key Insight: LUPIN LIMITED operates with high shipment frequency (360 shipments) at a per-shipment value of $27.0K, indicating a broad distribution network with many smaller, regular orders.
4MICRO LABS LIMITED
MICRO LABS LIMITED is the fourth-largest Losartan exporter from India, with a market share of 2.9% and a total export value of $8.7M across 676 shipments. Their average shipment value of $12.9K is below the market average of $27.6K, reflecting a high-volume, competitive pricing strategy.
MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• M/S LABOREX KENYA LIMITED — $2.5M across 191 shipments (28.2% of this supplier's total exports)
• AL-KAWKAB SCIENTIFIC — $2.0M across 153 shipments (22.6% of this supplier's total exports)
• AL-KAWKAB SCIENTIFIC — $1.9M across 148 shipments (21.9% of this supplier's total exports)
• SOMAPHAR — $1.5M across 119 shipments (17.5% of this supplier's total exports)
• PHILLIPS PHARMACEUTI — $857.7K across 66 shipments (9.8% of this supplier's total exports)
Key Insight: MICRO LABS LIMITED operates with high shipment frequency (676 shipments) at a per-shipment value of $12.9K, indicating a broad distribution network with many smaller, regular orders.
5ALEMBIC PHARMACEUTICALS LIMITED
ALEMBIC PHARMACEUTICALS LIMITED is the fifth-largest Losartan exporter from India, with a market share of 2.0% and a total export value of $5.9M across 222 shipments. Their average shipment value of $26.6K is below the market average of $27.6K, reflecting a high-volume, competitive pricing strategy.
ALEMBIC PHARMACEUTICALS LIMITED serves 5 named buyers in our database. J. KNIPPER & COMPANY, is the dominant customer, accounting for 56.0% of this supplier's tracked business. Top customers include:
• J. KNIPPER & COMPANY, — $3.3M across 124 shipments (56.0% of this supplier's total exports)
• J. KNIPPER & COMPANY, — $1.4M across 52 shipments (23.2% of this supplier's total exports)
• J. KNIPPER & COMPANY, — $781.2K across 29 shipments (13.2% of this supplier's total exports)
• J. KNIPPER & COMPANY, — $322.7K across 12 shipments (5.5% of this supplier's total exports)
• J. KNIPPER & COMPANY, — $125.9K across 5 shipments (2.1% of this supplier's total exports)
Key Insight: ALEMBIC PHARMACEUTICALS LIMITED operates with high shipment frequency (222 shipments) at a per-shipment value of $26.6K, indicating a broad distribution network with many smaller, regular orders.
6AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD is the fifth-largest Losartan exporter from India, with a market share of 0.9% and a total export value of $2.6M across 423 shipments. Their average shipment value of $6.2K is below the market average of $27.6K, reflecting a high-volume, competitive pricing strategy.
AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• AUROLOGISTICS LLC — $809.4K across 130 shipments (30.8% of this supplier's total exports)
• MILPHARM LIMITED — $539.5K across 87 shipments (20.5% of this supplier's total exports)
• AUROLOGISTICS LLC(AU — $522.1K across 84 shipments (19.8% of this supplier's total exports)
• AUROLOGISTICS LLC, (AUROBINDO PHARM — $385.1K across 62 shipments (14.6% of this supplier's total exports)
• APL SWIFT SERVICES ( — $375.9K across 60 shipments (14.3% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (423 shipments) at a per-shipment value of $6.2K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Losartan Flows
Once Losartan leaves the manufacturing plants of companies like ZYDUS LIFESCIENCES LIMITED and CIPLA LIMITED, it travels to 5 destination markets with a combined import value of $301.0M. United States absorbs the largest share at 44.6% ($134.1M), followed by Philippines (10.6%) and Sri Lanka (6.8%).
In United States — the top destination — named importers include EVERSANA LIFE SCIENCE SERVICES, NOVADOZ PHARMACEUTICALS LLC, J. KNIPPER & COMPANY. In Philippines, key buyers are NELPA LIFESCIENCES INC, UNILAB INC.
This geographic spread reflects Losartan's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Losartan Go? Top Importing Countries & Their Buyers
Trade flow of Losartan exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Losartan imports from India, with a total trade value of $134.1M across 971 shipments — representing a 44.6% share of all Losartan exports. The average shipment value of $138.1K is above the global average of $27.6K, indicating high-value procurement contracts or branded formulations. This market is served by 9 tracked buyers.
Named Losartan importers in United States: EVERSANA LIFE SCIENCE SERVICES is the largest buyer, accounting for 48.5% ($65.0M) of this market's total imports.
• EVERSANA LIFE SCIENCE SERVICES — $65.0M (48.5% of United States's total)
• NOVADOZ PHARMACEUTICALS LLC — $5.1M (3.8% of United States's total)
• J. KNIPPER & COMPANY — $4.6M (3.4% of United States's total)
Key Insight: United States's per-shipment average of $138.1K (400% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Losartan imports from India.
2Philippines
Philippines ranks as the second-largest destination for Losartan imports from India, with a total trade value of $32.0M across 151 shipments — representing a 10.6% share of all Losartan exports. The average shipment value of $212.0K is above the global average of $27.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Losartan importers in Philippines: NELPA LIFESCIENCES INC is the largest buyer, accounting for 36.1% ($11.6M) of this market's total imports.
• NELPA LIFESCIENCES INC — $11.6M (36.1% of Philippines's total)
• UNILAB INC — $10.6M (33.2% of Philippines's total)
Key Insight: Philippines's per-shipment average of $212.0K (668% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Philippines is a key market for Losartan imports from India.
3Sri Lanka
Sri Lanka ranks as the third-largest destination for Losartan imports from India, with a total trade value of $20.6M across 180 shipments — representing a 6.8% share of all Losartan exports. The average shipment value of $114.4K is above the global average of $27.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Losartan importers in Sri Lanka: BREATHEFREE LANKA PVT LTD is the largest buyer, accounting for 56.6% ($11.7M) of this market's total imports.
• BREATHEFREE LANKA PVT LTD — $11.7M (56.6% of Sri Lanka's total)
• SUNSHINE HEALTHCARE LANKA LIMITED — $4.3M (20.9% of Sri Lanka's total)
Key Insight: Sri Lanka's per-shipment average of $114.4K (314% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sri Lanka is a key market for Losartan imports from India.
4Chile
Chile ranks as the fourth-largest destination for Losartan imports from India, with a total trade value of $15.9M across 153 shipments — representing a 5.3% share of all Losartan exports. The average shipment value of $104.2K is above the global average of $27.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Losartan importers in Chile: OPKO CHILE S.A. is the largest buyer, accounting for 52.1% ($8.3M) of this market's total imports.
• OPKO CHILE S.A. — $8.3M (52.1% of Chile's total)
• OPKO CHILE S A — $3.8M (23.7% of Chile's total)
Key Insight: Chile's per-shipment average of $104.2K (277% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Chile is a key market for Losartan imports from India.
5United Kingdom
United Kingdom ranks as the fifth-largest destination for Losartan imports from India, with a total trade value of $9.2M across 0 shipments — representing a 3.0% share of all Losartan exports. The average shipment value of $9.2M is above the global average of $27.6K, indicating high-value procurement contracts or branded formulations.
Key Insight: United Kingdom's per-shipment average of $9.2M (33083% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Kingdom is a key market for Losartan imports from India.
People Also Ask — Losartan Supplier & Trade Network
Who are the top suppliers of Losartan from India?+
Which companies buy Losartan from Indian manufacturers?+
Where does Losartan exported from India go?+
What is the market share of the top Losartan supplier from India?+
What is the average shipment value for Losartan exports from India?+
Is Losartan manufactured in India and exported globally?+
Which country imports the most Losartan from India?+
Who are the buyers of Losartan in Philippines?+
How concentrated is the Losartan supplier market in India?+
How do I find verified buyers for Losartan in specific countries?+
Losartan Trade Network — Key Takeaways
- 1ZYDUS LIFESCIENCES LIMITED is India's dominant Losartan exporter with a 20.7% market share and $62.3M in total exports — making it the single most important sourcing entity in this market.
- 2The top 506 suppliers collectively account for 34.3% of all tracked Losartan exports, with a combined trade value of $301.0M.
- 3United States is the largest destination market, absorbing 44.6% of India's Losartan exports ($134.1M). Philippines (10.6%) and Sri Lanka (6.8%) follow.
- 4With 10.9K total shipments averaging $27.6K each, the Losartan export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include EVERSANA LIFE SCIENCE SERVICES, PRIORITY HEALTHCARE , BREATHEFREE LANKA PVT LTD, BREATHEFREE LANKA PR — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 141 countries
Network value: $301.0M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Losartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Losartan.
- 2.Flow Mapping: 506 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 10,898 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 141 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
10,898 Verified Shipments
506 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists